Literature DB >> 20098322

Vasospasm after aneurysmal subarachnoid hemorrhage: recent advances in endovascular management.

Laurent Pierot1, Mohamed Aggour, Jacques Moret.   

Abstract

PURPOSE OF REVIEW: In a rapidly advancing specialty, it is essential to review the recent studies of alternative new treatments and present their efficacy, safety and outcome. We discuss the recent advances in the endovascular treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage in the past few years with special focus on the literature regarding this subject in the last 18-24 months. RECENT
FINDINGS: The recent findings are as follows: effect of papaverine on brain oxygen; recent evaluation concerning nimodipine use; combined intraarterial and intravenous use of milrinone; illustration of the numerous recent studies on nicardipine; the safety and efficacy of high-dose intraarterial verapamil; outcome and adverse effects of intraarterial fasudil; transluminal balloon angioplasty; and recent evaluation of its efficacy and evaluation of its prophylactic use.
SUMMARY: Endovascular treatment, including intraarterial vasodilators and transluminal balloon angioplasty, has a very important place in the management of symptomatic vasospasm related to aneurysmal subarachnoid hemorrhage. The efficacy of intraarterial vasodilators has been proven. Numerous studies and analysis of different treatments of cerebrovascular vasospasm took place in the past period. This allowed more understanding and evaluation of their outcome, safety and efficacy helping physicians to choose better treatments to adopt. It emphasizes also the aspects that need more study and research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20098322     DOI: 10.1097/MCC.0b013e3283372ef2

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  13 in total

Review 1.  Biomarkers in neurocritical care.

Authors:  W Taylor Kimberly
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Higher dose intra-arterial milrinone and intra-arterial combined milrinone-nimodipine infusion as a rescue therapy for refractory cerebral vasospasm.

Authors:  Enes Duman; Fatma Karakoç; H Ulas Pinar; Rafi Dogan; Ali Fırat; Erkan Yıldırım
Journal:  Interv Neuroradiol       Date:  2017-09-28       Impact factor: 1.610

3.  Endovascular Rescue Therapy for Refractory Vasospasm: When and How?

Authors:  M Weiss; G A Schubert
Journal:  AJNR Am J Neuroradiol       Date:  2017-01-12       Impact factor: 3.825

4.  Endovascular treatment of severe vasospasm in nonaneurysmal perimesencephalic subarachnoid hemorrhage.

Authors:  Edgar A Samaniego; Guilherme Dabus; Karel Fuentes; Italo Linfante
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

5.  The Impact of Endovascular Rescue Therapy on the Clinical and Radiological Outcome After Aneurysmal Subarachnoid Hemorrhage: A Safe and Effective Treatment Option for Hemodynamically Relevant Vasospasm?

Authors:  Dorothee Mielke; Katja Döring; Daniel Behme; Marios Nikos Psychogios; Veit Rohde; Vesna Malinova
Journal:  Front Neurol       Date:  2022-05-09       Impact factor: 4.086

6.  A Site-Specific, Sustained-Release Drug Delivery System for Aneurysmal Subarachnoid Hemorrhage.

Authors:  Daniel Hänggi; Nima Etminan; Hans Jakob Steiger; Mark Johnson; M Melissa Peet; Tom Tice; Kevin Burton; Bruce Hudson; Michele Turner; Angela Stella; Parissa Heshmati; Cara Davis; Herbert J Faleck; R Loch Macdonald
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

Review 7.  Anesthetic management of patients with intracranial aneurysms.

Authors:  Alaa A Abd-Elsayed; Anthony S Wehby; Ehab Farag
Journal:  Ochsner J       Date:  2014

8.  Morphological changes of intracranial pressure quantifies vasodilatory effect of verapamil to treat cerebral vasospasm.

Authors:  Xiuyun Liu; Jeffrey R Vitt; Steven W Hetts; Koa Gudelunas; Nhi Ho; Nerissa Ko; Xiao Hu
Journal:  J Neurointerv Surg       Date:  2020-01-20       Impact factor: 5.836

9.  Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil.

Authors:  Chunyun Liu; Yanhua Li; Jiezhong Yu; Ling Feng; Shaowei Hou; Yueting Liu; Mingfang Guo; Yong Xie; Jian Meng; Haifei Zhang; Baoguo Xiao; Cungen Ma
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

10.  MicroRNA-513b-5p targets COL1A1 and COL1A2 associated with the formation and rupture of intracranial aneurysm.

Authors:  Zheng Zheng; Yan Chen; Yinzhou Wang; Yongkun Li; Qiong Cheng
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.